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Rationale. The family of calcium-activated potassium channels consists of four members with varying biological functions and
conductances. Besides membrane potential modulation, SK channels have been found to be involved in cardiac pacemaker cell
development from ES cells and morphological shaping of neural stem cells. Objective. Distinct SK channel subtype expression in
ES cells might elucidate their precise impact during cardiac development. We chose SK channel subtype 4 as a potential candidate
influencing embryonic stem cell differentiation. Methods. We generated a doxycycline inducible mouse ES cell line via targeted
homologous recombination of a cassette expressing a bicistronic construct encoding SK4 and a fluorophore from the murine
HPRT locus. Conclusion. We characterized the mouse ES cell line iSK4-AcGFP. The cassette is readily expressed under the control
of doxycycline, and the overexpression of SK4 led to an increase in cardiac and pacemaker cell differentiation thereby serving as a
unique tool to characterize the cell biological variances due to specific SK channel overexpression.
1. Introduction
Calcium-activated potassium channels (SKCas) of small and
intermediate conductance represent a family of pore proteins
which selectively transduce transmembranous potassium ion
currents with differing conductance capacity [1]. Through-
out the organism, these channels are expressed in tissues
derived from all three germ layers, the central nervous tissue
[2, 3], hematopoietic and muscle cells [4–6], or intestine
epithelial cells [7], with distinct expression patterns. In
excitable cells, SKCas are mostly involved in the generation
of the hyperpolarization following the action potential [1].
Besides the modulation of the membrane potential in various
tissues and cell populations, these ion channels have been
found to be involved in a number of biological processes, for
example, proliferation, cell differentiation, and cell morphol-
ogy. As these mechanisms are present in stem or progenitor
cells of different origin and potency, a role in developmental
processes can be hypothesized [8–11]. Although the distinct
mechanisms have not been fully understood yet, studies
have shown on the one hand that the modulation of the
intracellular calcium signaling by this channel family and
its protein partner calmodulin might play a substantial role.
On the other hand we showed in earlier studies that SKCas
are important players as modulators of the cytoskeleton
via specific protein-protein interaction [9, 12]. To elucidate
the developmental involvement of SK channels we utilized
embryonic stem cells (ESCs) representing a bona fide model
to investigate the specific role of distinct proteins during
development and cell differentiation [13, 14]. Moreover,
2 Stem Cells International
SKCas have shown to be involved in the regulation of
proliferation in several types of stem cells [10, 15–17].
Recently, we were able to describe the abundance of SK
channels subtypes in ESCs with SK4 being predominantly
expressed. These findings were extended by our group to
murine pluripotent stem cells, namely, ES and iPS cells
(Liebau, unpublished data and [5]). We found in consequent
experiments that increased SK channel activity resulted in a
strong and fast differentiation of ES cells followed by a cell
fate determination to the cardiac lineage. Precise characteri-
zation of the arising cardiomyocytes revealed the generation
of a predominant population of cardiac pacemaker-like cells
upon SKCa activation in both ES and iPS cells (Liebau,
unpublished data and [5]). In fact, SK4 appeared to play
a superior role during this process as its knockdown in
embryonic stem cells led to a significantly decreased rate of
cardiac differentiation [5]. Nevertheless, the impact of each
particular SKCa subtype remains elusive. Apart from that,
it remained unclear whether the inhibition of proliferation
via SK channel activity in ES cells was solely due to a direct
impact on the mitotic cell cycle or whether enhanced differ-
entiation diminished proliferation of stem cells. This might
be explained by the fact that the activation via the SKCa
activator EBIO activates not only one, but all 4 subtypes,
most likely having overlapping functions within the SKCa
family. Unfortunately, loss of function experiments usually
do not allow a stage-specific analysis and chemical inhibitors
commonly harbor off-target effects. Thus, a clean and bias-
free genetic system is required to dissect the contribution of
each SK subtype towards the cardiac program.
Cardiac development follows a specific developmental
cascade that is initiated by early mesendoderm and meso-
derm formation while the heart fields arise from cells in
the anterior lateral plate mesoderm of the early embryo.
These fields include the precursors of both myocardial and
endocardial cells, although there is apparently no common
pool of bipotential precursors for these two heart cell lineages
[18, 19]. This is followed by the anlagen of a cardiogenic plate
and formation of cardiac progenitor cells with varying poten-
tial to differentiate into the various cardiac subtypes. The
next step is the specification of cardiomyocytes during the
formation of the cardiac tissue [20, 21], shortly followed by
expression of differentiation markers [22]. The early cardiac
zone exhibits inducing activities on cardiac differentiation.
This activity is not only driven by the cardiac zone but also
from the anterior endoderm [19, 23–25]. Genes encoding
factors of the NK homeodomain, GATA, T-box, and other
families were found to exert the functions of inducive signals
during specification, patterning, and differentiation of the
heart [18]. Subsequently, structural and functional proteins
are required during late tissue formation and the long
functional period of cardiomyocytes and their respective
subtypes, such as pacemaker cells of the conduction system
are expressed.
The role of SK channels during this process remains to be
determined as their mechanistic position within the cardiac
program is still underdeveloped. Genetic engineering of ES
cells, a commonly used developmental in vitro model for
studying cardiac development, is often limited by several
factors. This includes, for example, low or varying trans-
fection efficiencies in transiently overexpressing constructs
or, in the case of stable transfection, random insertions of
the gene of interest, leading to varying insertion numbers
and unforeseen side effects in the cell. Apart from that, a
controllable expression of the inserted construct is highly
desirable [26, 27]. Here we report on the generation and
characterization of an ESC line expressing SK4 with a
doxycycline-dependent expression level and its potential
impact on cardiac development from embryonic stem cells.
2. Material and Methods
2.1. ES Cell Culture. Embryonic stem (ES) cells were cul-
tivated in the undifferentiated state on primary embryonic
mouse fibroblasts. The mouse embryonic fibroblasts (MEFs)
were inactivated by mitomycin C (Sigma-Aldrich, St. Louis,
USA; final concentration 0.01 mg/mL) incubation for 2.5 h
[28, 29] before using them for ES cell culture. MEF cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM;
Invitrogen, Carlsbad, CA, USA) supplemented with 10%
FCS (Invitrogen), L-glutamine (Invitrogen; final concen-
tration 2 mM), nonessential amino acid mix (Invitrogen;
stock solution diluted 1 : 100), sodium pyruvate (Invitrogen;
final concentration 1 mM), and β-mercaptoethanol (Sigma-
Aldrich; final concentration 10−5 M). ES cell culture was
performed in Knockout DMEM (Invitrogen) supplemented
with 15% FCS (Invitrogen; stem cell tested), 1000 units/mL
LIF (ESGRO), and the same additions as used in the
fibroblast medium [30]. ES cells were trypsinized (0.1%
Trypsin/0.02% EDTA mixed 1 : 1) and replated every 24–
36 h on inactivated mouse embryonic fibroblasts growing on
tissue culture dishes (Nunc, Wiesbaden, Germany).
2.2. Generation of iSK4 Cells. One day before the nucleo-
fection procedure, A2lox.cre cells were imposed to 1 μg/mL
of doxycycline to induce Crerecombinase. ES cells were
nucleofected using the Nucleofector Technology (Lonza)
according to the manufacturer procedures. The Nucle-
ofector Kit for Mouse Embryonic Stem Cells has been
used upon further optimization together with program A1
and 10 μg of DNA (SK4-IRES-acGFP p2lox vector) per 5
million parental A2lox.cre embryonic stem cells. Nucleo-
fected cells were plated on neomycin-resistant, mitomycin-
C-inactivated murine embryonic fibroblasts. Two days after
nucleofection the assortment in ES cell medium supple-
mented with neomycin (400 μg/mL) was started. Neomycin-
resistant clones were picked on inactivated feeder cells and
expanded for further analysis after 10 days of selection.
2.3. In Vitro Differentiation of ES Cells. In vitro differentia-
tion of ES cells was carried out according to the standard pro-
tocol using the hanging drop method as described in [30, 31].
Iscove’s modified Dulbecco’s medium (IMDM, Invitrogen)
supplemented with 10% FCS (Lonza, Basel, Switzerland),
GlutaMax, NEAA, and freshly prepared monothioglycerol
(Sigma-Aldrich; final concentration 450 μM) were used for
differentiation. Briefly, 400 cells per 20 μL differentiation
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medium were placed on the inside of lids of Petri dishes filled
with 10 mL PBS and were cultivated for 2 days in hanging
drops. After another two days of cultivation on bacterio-
logical dishes, these 4-day-old (4 d) embryoid bodies (EBs)
(n = 20) were plated on (0.2%) gelatin-coated 6-well dishes
or cover slips for RNA or immunofluorescence analysis and
assayed at specific time points. RNA samples were collected
10 days after EB plating. For doxycycline (Sigma-Aldrich)
treatment a 1 mg/mL stock solution was prepared in sterile
water and EBs were treated at final concentration of 1 μg/mL
doxycycline in differentiation medium from day 0 until day
10 after EB plating. Doxycycline was added to the culture
medium every second day with regular medium changes. All
experiments were performed at least three times. For mono-
layer conditions, doxycycline was added to ES cells which
were kept under pluripotency conditions for three days of
culture in a final concentration of 1 μg/mL. Afterwards, cells
were collected for RNA and immunostaining analysis.
2.4. Genomic PCR. Genomic ES cell DNA was isolated by the
Blood & Tissue Kit (QIAGEN, Hilden, Germany). For PCR
reaction recombinant Taq DNA polymerase (Invitrogen) was
used. The reaction was performed in 25 μL containing 1 μL
DNA, 0.25 μL Dream Taq/Herculase and the following final
supplements: 2.5 μL PCR buffer (10X), 2 μL 1.5 mM MgCl2,
0.5 μL of each 10 mM dNTP, 0.3 μL of each primer. PCR
conditions for ES cell analysis started with denaturation at
94◦C for 3 min followed by a primer-dependent number
of cycles with denaturation at 94◦C for 30 s, annealing
temperature at 61◦C for 45 s, and product elongation at 72◦C
for 1 min. The following gene locus specific primer sequences
have been used: LOXIN R 5′-ATA CTT TCT CGG CAG GAG
CA-3′, and LOXIN F 5′-CTA GAT CTC GAA GGA TCT GGA
G-3′.
2.5. Quantitative One Step Real-Time PCR. One-step real
time PCR was carried out according to [9, 32] the Rotor-
Gene Q usage instructions (QIAGEN). Amplification was
monitored and analyzed by measuring the binding of the
fluorescence dye SYBR Green I to the minor groove of
double-stranded DNA. 1 μL of total RNA was reverse-
transcribed and subsequently amplified using QuantiFAST
SYBR Green RT-PCR Master mix (QIAGEN). QuantiTect
primer assays (QIAGEN) were used in all experiments.
Each RNA preparation was tested for genomic DNA con-
tamination in a LightCycler RT-PCR by replacing reverse
transcriptase with water. Tenfold dilutions of total RNA were
used as an external standard curve. PCR efficiency results
from the slope of these standard curves. Internal standards
(house-keeping gene) and samples were simultaneously
amplified. RT-PCR conditions started with 20 min of RT at
50◦C, followed by activation of Taq-polymerase at 95◦C for
15 min. 45 cycles with denaturation at 94◦C for 15 s, 58◦C
for 20 s, and 72◦C for 16 s amplified all described products
with a PCR efficiency close to 3.3 (exact doubling of PCR
product). To verify the specificity of the PCR amplification
products, melting curve analysis was performed using the
following thermal cycling profile: 95◦C for 0 s, 65◦C for 15 s,
and ramping to 95◦C with stepwise signal acquisition. The
concentration of each transcript was calculated by reference
to the respective standard curve. Relative gene expression
was expressed as a ratio of target gene concentration to
housekeeping gene hydroxymethylbilane synthase (HMBS)
concentration.
2.6. Immunocytochemistry. Immunofluorescence analysis
was carried out as shown in [33, 34] with either ES cells
or differentiating EBs cultivated on 0.2% gelatin-coated
coverslips. The cells were rinsed in PBS and fixed with PBS
containing 4% paraformaldehyde at room temperature for
20 min. For Oct4 staining cells were incubated for 10 min in
0.2% Triton X (Sigma-Aldrich) followed by 30 min incuba-
tion in 5% goat serum in 0.5% fish skin gelatin (Sigma) to
block unspecific binding. Then preparations were incubated
with the primary antibody against Oct3/4 (Santa Cruz; Santa
Cruz, USA; diluted 1 : 400) at RT in a humidified chamber for
1 h. In case of SSEA1 staining (Developmental Hybridoma
Banks, 1 : 500) the permeabilization step was skipped. After
washing three times in PBS, cells were incubated for another
1 h at 37◦C with the respective Alexa fluorophore-labeled
secondary antibodies. Samples were subsequently embedded
in VECTASHIELD mounting medium (Vector, Burlingame
USA) and analyzed by fluorescence microscopy.
2.7. Immunoblotting. iSK4 cells were pelleted and lysed in
RIPA lysis buffer (50 mM tris-HCl pH 8.8, 1% NP-40,
0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 5 mM
EDTA, 10% glycerol, 2.5 mM MgCl2, protease, and phos-
phatase inhibitor cocktail) (Roche, Mannheim, Germany).
After centrifugation at 14,000 rpm for 10 min, protein con-
centrations were measured in the lysates. 100 μg of total
protein was resuspended in Laemmli buffer and subjected to
SDS-PAGE. The gels were blotted onto a PVDF membrane
and blocked with 5% milk in 0.1% TBS-Tween buffer
(TBS-T). After blocking, SK4-specific antibody was applied
(1 : 1000 4◦C over night incubation) (Cell Application,
San Diego, USA), beta-actin (1 : 1000). After washing with
TBS-T samples were incubated with secondary horseradish
peroxidase- (HRP-) labeled antimouse (1 : 4000) (Roche)
or antirabbit IgG (1 : 5000) (Bio-Rad, Munich, Germany)
antibodies in blocking solution for 1 h at room temperature.
ECL signals were visualized and quantified using a Fujifilm
LAS with the corresponding quantification software.
2.8. FACS Analysis. A single-cell suspension was generated
from iSK4 using trypsin/EDTA. Finally the washed pellet
was dissolved in 5% FCS/PBS and analyzed on an LSR
FACS machine (BD Bioscience, San Jose, USA) for GFP
fluorescence encoded from the AcGFP cassette in iSK4 cells
upon doxycycline exposure. Data were analyzed using the
WinMDI software version 2.8.
2.9. Proliferation Assay. Cell proliferation assays were per-
formed using the CellTiter-Glo Luminescent Cell Viability
Assay (Promega, Madison, USA) according to the manufac-
turer’s protocol.
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Figure 1: Effects of doxycycline treatment on A2lox.cre ES cells. (a, b) SSEA-1 (a) and Oct4 (b) staining upon 3 days of treatment with
1 μg/mL of doxycycline revealed no difference in expression levels. (c) EBs were plated, and the percentage of EBs containing cardiac cell
beating clusters was determined in dox-treated versus untreated cultures on day 10 after EB plating on day 4.
3. Results
3.1. Generation of SK4-AcGFP Inducible Knock in ES Cell Lines
(iSK4). First, we assessed whether a doxycycline inducible
system fits our requirements of being neutral with respect
to differentiation of embryonic stem cells. To this end, we
used wild-type ES cells and treated them with the respected
concentration of doxycycline for three days. We could not
observe any differences neither on the expression of common
pluripotency markers such as SSEA1 or Oct4 (Figures 1(a)
and 1(b)) nor on the numbers of cardiac beating clusters
(Figure 1(c)). Next, we started out with the construction of
Stem Cells International 5
neoRTRE
lox
2272
lox
2272
lox
2272
loxP
PGK ATG SK4 IRES AcGFPSt
op
St
op
St
op
loxP
pROSA
+
HPRT
HPRT
TRE SK4 IRES AcGFP loxPPGK ATG neoR
rtTA
rtTA
rtTA
Cre
Lox targeting plasmid constructs
Hprt locus on X-chromosome
ROSA26 locus on
chromosome 6 
DOX
DOX
(a)
450 bp
CGR8 iSK4
(b)
Figure 2: Construction of the iSK4 cell line. (a) Scheme of the expression cassette integrated into the desired loci. The ES cell line A2lox.cre
harbors an rtTA in the constitutive ROSA26 locus on chromosome 6. A neomycin (noeR) resistance is recombined upon integration of
the targeting vector. Recombination of the construct into the prepared site on the X-chromosome is facilitated by Cre. Transgenic cells can
subsequently be selected by G418 (neo). tetOP: tetracycline response element; PGK: phosphoglycero kinase promoter; ATG: methionine
initiation codon; black triangle: lox recognition sequence for Cre recombinase; GFP: green fluorescent protein; Neo: truncated neomycin
(G418) resistance gene; pA: polyadenylation sequence. (b) Lox-in PCR verifies the correct integration of the expression cassette at determined
loci on chr6 by amplifying a product at the size of ∼450 bp. Untargeted ES cells were used as a control.
the desired SK4 expressing plasmid. The SK4 construct (a
kind gift of Dr. Begenisich) was originally cloned into the
pcDNA3.1 vector [35]. The construct was amplified by PCR
introducing the required restriction sites to the sequence and
was subsequently ligated into the pIRES2-AcGFP vector. In
this vector, the green fluorophore is encoded by the same
RNA that harbors the channel protein code but separated
by an internal ribosome entry sequence (IRES) leading to
the translation of a GFP which is not fused to the gene of
interest. This was desirable as fluorophores are large proteins
of approximately 30 kD and, fused to other proteins, may
cause misfolding, wrong localization, or impaired function
of the protein of interest [36]. This vector harbors the green
fluorophore found in the jellyfish Aequorea coerulescens (Ac).
For the controlled and defined expression of the constructs
in ES cells we utilized a genetically modified ES cell line
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Figure 3: Characterization of iSK4 cells. (a) Flow cytometry by FACS shows a major proportion of the doxycycline-treated cells to
exhibit green fluorescence (>75%). (b, c) Neomycin-selected iSK4 clonal cultures show dox-dependent elevation of SK4 proteins. (b)
Iimmunocytochemistry using specific SK4 antibodies shows highly elevated protein levels of SK4 in the colonies after 1 day of doxycycline
treatment. Dox-treated cells exhibit the AcGFP fluorescence (green) in contrast to controls. Both treated and untreated cells express
SK4 proteins (red) with a strong increase in the dox-treated cells. Elevated SK4 proteins upon dox treatment was underlined by (c) by
immunoblot. Nuclei are stained by DAPI (blue). Scale bars as indicated. (d) SK4 transcript increase upon doxycycline treatment is validated
by real-time one-step RT-PCR.
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Figure 4: Doxycycline treatment alters cell behavior. (a) Elongated dox treatment for 3 days alters the pluripotency and morphology of
the ES cells. Oct3/4 proteins (red) are decreased, and green fluorescence is solely expressed by dox-treated cells. (b) In line, the ES cell
marker SSEA1 is lost during dox treatment (red), and the actin cytoskeleton, visualized by the f-actin marker phalloidin, is altered upon dox
treatment. (c) Proliferation of iSK4 cells is not changed by dox-treatment shown in a proliferation assay. (n = 4) for all experiments. Nuclei
are stained by DAPI (blue). Scale bars as indicated.
and the corresponding vector system initially generated by
Iacovino et al. (submitted). The murine ES cell line (called
A2lox.cre) allows the targeting of the requested transgene to
an X-chromosomal locus, upstream of HPRT, in a control-
lable manner, as the pROSA26 locus already harbors a reverse
tetracycline transactivator. The Crerecombinase encoding
cDNA has been inserted into the HPRT locus in between
loxP and loxM within A2lox.cre cells and is self-excised [37].
The cre-cassette is exchanged for the plasmid of interest (here
SK4-pIRES AcGFP), upon induction of the cre protein by
doxycycline (Figure 2(a)). This system has been shown to be
suitable to dissect the impact of certain factors on cardiac
differentiation in ES cells [38, 39]. For SK4, the complete
cassette consisting of the SK4 coding sequence, the pIRES
site, and the GFP was excised by restriction enzymes suitable
for the p2lox system. Doxycycline inducible SK4 ES cells
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Figure 5: Cardiac differentiation is increased upon doxycycline treatment. (a) The number and size of cardiac clusters arising in dox-treated
and untreated cultures were evaluated and counted. Dox treatment leads to a strong increase in both number and size of spontaneously
beating cell clusters 10 days after plating. Small clusters: <100 μM; big clusters >100 μM. (b–e) Expression of cardiac marker genes upon
induction of SK4. On mRNA level, the cardiac specific transcripts Myh2 (b), Myh6 (c), Myl7 (d), and Hcn4 (e) are significantly elevated
upon dox treatment (n = 4). (f) This is also evident in immunocytochemical stainings using cardiac specific antibodies directed against α-
actinin (red). The size of cardiac clusters is highly increased 10 days after plating. Nuclei are stained by DAPI (blue). Scale bars as indicated.
were generated by subcloning the SK4 cDNA into p2Lox [40]
and using the derivative p2Lox-SK4 to target the inducible
locus of A2Lox.cre ES cell (Iacovino et al., submitted). This
cell line is an improved version of A2Lox [40] in which
a floxed cre-cassette has been engineered downstream of a
doxycycline inducible promoter upstream of HPRT on the X
chromosome. A2Lox.cre cells were treated with 500 ng/mL
doxycycline for 24 hours and harvested by trypsinization.
Cre expression catalyzed replacement of the cre-cassette by
the incoming SK4 cassette from p2Lox-SK4. Summarized,
we chose a doxycycline controlled expression system which
on the one hand harbors a cassette generating an untagged
full length channel protein. On the other hand this system
allowed us to select stable transfected ES cells by either FACS
sorting for the soluble green fluorescing protein or via the ES
cell-line-specific neomycin resistance that is solely expressed
in the case of successful transfection. First, we transfected
A2lox.cre cells with the according construct. Subsequently,
neomycin-resistant clones were manually picked and sub-
cultured for further analysis. Next, we checked whether the
inducible cassette exchange was successful via analyzing the
genomic locus. The band at 450 bp marks the successful
targeting event in the cell line while no band was visible in
nontransgenic CGR8 ES cells (Figure 2(b)).
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3.2. Characterization of iSK4 ES Cells. In a primary approach
we sought to verify the appropriate features of the transgenic
cells. Therefore, we tested the desired expression of the green
fluorophore in a doxycycline-dependent manner. In compar-
ison to the untreated cultures FACS analysis of doxycycline-
treated iSK4 cells showed a robust expression of the AcGFP
regarding most of the subcultured clones (Figure 3(a)).
Secondly, as expected, the induction of the transgene
upon application of doxycycline treatment was detectable
on protein levels and mRNA. Protein levels upon dox
treatment were investigated either by immunofluorescence
or by immunoblotting. We could detect both the endogenous
expression of the channel protein and a specific increase
of the expected transgenic channel proteins (Figures 3(b)–
3(c)). This was further underlined by the detection of both
the endogenous and overexpressed channel transcripts at
doxycycline-dependent quantities (Figure 3(d)), investigated
by qPCR. Further experiments were performed with several
clones expressing comparable levels of SK4 under doxycy-
cline (not shown).
3.3. Role of SK4 Overexpression in iSK4 Cell Lines. Although
we observed in earlier studies that SK4 activity is crucially
involved in ES cell differentiation and subsequent generation
of cardiac and cardiac pacemaker-like cells, we did not yet
know what impact the simple overexpression of this channel
would have on the generated iSK4 ES cell line under several
conditions. This is of particular interest as expression does
not necessarily mean activity in case of ion channels. In fact,
this would point to signaling events which are not directly
linked to the membrane potential itself, as we previously
reported for neural stem cells [12]. In a first step we looked
for both initiation of differentiation and changes of the
cell cycle upon doxycycline supplementation. In immuno-
cytochemical stainings we observed a clear change of ES
cell colony morphology and loss of pluripotency markers
in iSK4 cells upon doxycycline-induced expression of SK4.
This was true for the common markers Oct3/4 and SSEA1,
respectively. The GFP protein seen in the green channel
marks the transgene expression of the SK4 protein during
this assay (Figures 4(a)–4(b)). ES cells are characterized by
a unique cell cycle regulation which comprises fast self-
renewing of this cell system and differentiation is usually
accompanied by changes in the proliferation rates in ES
cells. Nevertheless, cell titer glow assays did not show a
change in proliferation capacity upon SK4 overexpression
(Figure 4(c)).
3.4. Cardiac Differentiation Capacity of iSK4 ES Cells. SK
channel activity strongly drives the cell fate of differentiating
ES cells towards the cardiac lineage. In particular this was
the case upon embryoid body-induced germ layer formation
and subsequent increased SK channel activity after EB plat-
ing. Different doxycycline-treatment regimens were applied
during differentiation, and cultures were analyzed regarding
their cardiac differentiation potential, according to morpho-
logical criteria at several time points (data not shown). In the
end, we discovered that continuous doxycycline treatment
during differentiation had the strongest cardiac inducing
effect. Obviously, increased SK4 expression led to highly
elevated numbers of cardiac clusters with an additional
increase in the size of the beating areas as shown by the high
abundance of small clusters and a significant switch to form
large clusters in comparison to control cells (Figure 5(a)).
Next, we wanted to know whether this cardiac inducing effect
is further mirrored by increased cardiac gene expression
levels. A strong upregulation of the general cardiac marker
gene Myl2 (4.6 fold; Figure 5(b)) was observed upon SK4
expression. Also atrial-specific genes such as Myh6 [41, 42]
(5.6 fold) and Myl2a (2.07 fold) were strongly up-regulated
(Figures 5(c) and 5(d)). This suggested us to investigate
the expression levels of HCN4, belonging to the family
of channels responsible for the hyperpolarization activated
current, I f . HCN4 plays a major role in the pacemaker
potential of the sinoatrial node (SAN). It labels pacemaker
tissues including the SAN, serves as an excellent nodal
marker, and was strongly up-regulated upon SK4 induction
(5.48 fold, Figure 5(e)). This was further underlined by the
immunocytochemical detection of large α-actinin-positive
clusters in the dox-treated cultures compared with only a few
positive cells under control conditions (Figure 5(f)).
4. Discussion
Here we report the successful generation and characteriza-
tion of a murine embryonic stem cell line overexpressing
the subtype 4 of calcium-activated potassium channels in a
doxycycline dependent manner. These cells were investigated
concerning their impact of SK4 on cardiac differentiation
derived from ES cells.
In an earlier study we were able to show that murine ES-
cells change their cell fate determination in an SK activity
dependent manner. Increased SK activity led to the differen-
tiation of ES cells into a high proportion of cardiomyocytes
with the majority of the cells showing functional and
morphological properties of cardiac pacemaker cells. These
experiments were mainly based on the potentiation of SK
channel activity mediated by the commonly used chemical
compound 1-EBIO (1-ethyl-2-benzimidazolinone). Mecha-
nistically, the EBIO-induced increase in Ca2+-sensitivity is
suggested to result from the interaction of the benzimida-
zolinone with the Ca2+ gating apparatus of SK channels [43].
EBIO is known to nonselectively activate all SK subtypes
[44] which makes it difficult to dissect the distinct biological
role of the individual SK channel subtypes. In addition,
the functional potassium gating pore is composed of four
subunits which can consist of either 4 similar SK channel
proteins (homomeric) or can be a mix of several different SK
subunits (heteromeric) in vitro, leading to functional alter-
ations [45], and in vivo [46, 47]. Furthermore, all SK channel
subtypes display a variety of splice variants with yet unclear
functional diversity [47–50]. In our primary studies we tried
to dissect cardiac inducing effects upon SKCa activity by
applying different kinds of inhibitors. However, these exper-
iments were partly biased by cytotoxicity of the inhibitors.
Therefore, we generated SK4 knockdown cells which showed
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that depletion of SK4 “rescues’’ this inductive effect by
strongly diminishing cardiac differentiation in these cultures
[5]. Still, the mechanistic role of SK4 channel remained
unclear. This led us to the idea of systematically exploring
the exact role of this subtype during ES cell differentiation by
applying a clean and straightforward genetic system allowing
stage-specific expression of SK4 in ES cells. Several gain
of function systems, for example, lentiviral transduction or
transfection followed by selection for stable clones were
considered for these approach. However, none of this
approaches fulfilled all the respective criteria in one system,
namely, (i) inducible and (ii) dose-dependent expression of
the inserted cDNA (iii) from a defined genetic locus (iv)
without random insertion-based bias of data interpretation
[37]. These requirements led us to use A2lox.cre cells due to
the following superior characteristics. First of all, this system
allows a simple cloning of the gene of interest in a stable
plasmid vector which comprises easy-to-use restriction sites
for ligation. Secondly, the targeting strategy to a specific locus
circvents insertion-based gene dysfunction. Together with
the doxycycline inducible transcript expression of SK4 all
mentioned problems were solved and allowed us to study
the cell biological and developmental role of this SK channel
subtype in ES cells. We found a decrease of pluripotency
marker proteins upon overexpression for several days. Still,
in contrast to direct increased SK channel activity by 1-EBIO
in nontransgenic ES cells, we could not observe a change
in proliferation rates under SK4 overexpressing conditions
in iSK4 cells. Several reasons might be responsible for that
finding, for example, the influence of other SK channel sub-
types, heteromeric channel composition or ES-cell-specific
splice variants. As for the next step, we investigated several
regimens of stage-specific overexpression of SK4, starting
with doxycycline treatment during distinct phases of cardiac
in vitro differentiation (day 0–2: mesendoderm formation;
day 2–4: mesoderm formation; day 4–9: formation of cardiac
progenitors). We found that concerning cardiac differen-
tiation, continuous transgene activation was successfully
inducing cardiac myocyte generation. We could proof that
by increased mRNA levels for cardiac transcripts and on
protein levels. This clearly underlined the specific role of
SK4 channel proteins during ES cell differentiation towards
a cardiac cell fate. The ability to modulate expression times,
expression in various cell stages and in a quantitative manner
finally gives us the possibility to study these channel proteins
under further conditions. Furthermore, it comprises the
possibility to investigate participating signals which support
or mediate SK channel-induced mechanisms. Solely under
circumstances which combine understatement of SK channel
behavior with their influence on cellular mechanisms we
might be able to translate SK channel-mediated stem cell
differentiation into the human system.
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